Medications

New SARS-CoV-2 neutralizing antibody enters clinical phase

Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer Ingelheim today announced the initiation of Phase 1/2a clinical investigation of BI 767551, a ...

Oncology & Cancer

Breakthrough discovery to transform prostate cancer treatment

A novel formulation of the prostate cancer drug abiraterone acetate—currently marketed as Zytiga—will dramatically improve the quality of life for people suffering from prostate cancer, as pre-clinical trials by the University ...

page 7 from 16